1. Shen, Jie, Zhou, Lihui, Ye, Ke, Chen, Chao, Zhan, Renya. 2024. The role of SPI1/VSIG4/THBS1 on glioblastoma progression through modulation of the PI3K/AKT pathway. In Journal of advanced research, , . doi:10.1016/j.jare.2024.06.023. https://pubmed.ncbi.nlm.nih.gov/38960279/
2. Antunes Andrade, Fabiana, Goeldner Eibofner, Isabela, Pieczarka, Cristhine, Jose de Messias-Reason, Iara, P Velavan, Thirumalaisamy. 2021. Impact of VSIG4 gene polymorphisms on susceptibility and functional status of rheumatoid arthritis. In International journal of immunogenetics, 48, 260-265. doi:10.1111/iji.12533. https://pubmed.ncbi.nlm.nih.gov/33645007/
3. Miao, Jiansen, Tu, Yiting, Jiang, Junchen, Wang, Xiangyang, Jin, Haiming. 2024. VSIG4 inhibits RANKL-induced osteoclastogenesis by enhancing Nrf2-dependent antioxidant response against reactive oxygen species production. In International journal of biological macromolecules, 260, 129357. doi:10.1016/j.ijbiomac.2024.129357. https://pubmed.ncbi.nlm.nih.gov/38216011/
4. Reißing, Johanna, Lutz, Philipp, Frissen, Mick, Stallmach, Andreas, Bruns, Tony. 2021. Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality. In JHEP reports : innovation in hepatology, 4, 100391. doi:10.1016/j.jhepr.2021.100391. https://pubmed.ncbi.nlm.nih.gov/34917912/
5. Pan, Zongfu, Bao, Lisha, Lu, Xixuan, Huang, Ping, Ge, Minghua. 2022. IL2RA+VSIG4+ tumor-associated macrophage is a key subpopulation of the immunosuppressive microenvironment in anaplastic thyroid cancer. In Biochimica et biophysica acta. Molecular basis of disease, 1869, 166591. doi:10.1016/j.bbadis.2022.166591. https://pubmed.ncbi.nlm.nih.gov/36328145/
6. Zheng, Xiwang, Tong, Tong, Duan, Lianrui, Yang, Tao, Yang, Lijun. 2024. VSIG4 induces the immunosuppressive microenvironment by promoting the infiltration of M2 macrophage and Tregs in clear cell renal cell carcinoma. In International immunopharmacology, 142, 113105. doi:10.1016/j.intimp.2024.113105. https://pubmed.ncbi.nlm.nih.gov/39260310/
7. Liu, Matthew A, Shahabi, Shandy, Jati, Suborno, Ghosh, Gourisankar, Mahata, Sushil K. 2022. Gut microbial DNA and immune checkpoint gene Vsig4/CRIg are key antagonistic players in healthy aging and age-associated development of hypertension and diabetes. In Frontiers in endocrinology, 13, 1037465. doi:10.3389/fendo.2022.1037465. https://pubmed.ncbi.nlm.nih.gov/36440192/
8. Zheng, Congying, Mao, Chengliang, Tang, Kai, Shu, Hang. 2023. VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway. In Neuropsychiatric disease and treatment, 19, 1397-1408. doi:10.2147/NDT.S406782. https://pubmed.ncbi.nlm.nih.gov/37292180/
智鼠故事 
